谷胱甘肽联合前列地尔治疗脓毒症急性肾损伤的效果

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (36 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the effect of Glutathione combined with Alprostadil treating acute kidney injury in sepsis.Methods The clinical data of 80 patients with acute kidney injury in sepsis admitted to the Department of Intensive Medicine of the Second People′s Hospital of Baiyun District，Guangzhou from January 2017 to June 2019 were analyzed retrospectively.According to the different drug treatment methods，they were divided into the combined group and the control group，40 cases in each group.The control group received routine intravenous drip of Alprostadil，10 μg/time，qd;the combined group received glutathione treatment on the basis of the control group，0.6 g/time，qd，both groups were treated for 10 days.The curative effect at 10 days after treatment and the changes in serum tissue plasminogen activator (TPA) and plasminogen activator inhibitor (PAI-1) levels of the two groups were observed;the acute physiology and chronic health scores (APACHE Ⅱ)，systemic infection-related organ failure score (SOFA) were used to assess the changes in patients′ condition.Results The total effective rate of the combined group was higher than that of the control group，the difference was statistically significant difference (P＜0.05);the serum TPA and PAI-1 levels of the combined group were lower than those of the control group，there were statistically significant differences(P＜0.05);the APACHEⅡand SOFA scores of the combined group were lower than those of the control group，the differences were statistically significant (P＜0.05).Conclusion Glutathione combined with Alprostadil can improve the therapeutic effect and reduce the levels of TPA and PAI-1 in patients with acute kidney injury in sepsis.

Key words： Glutathione Alprostadi Sepsis Acute kidney injury Tissue plasminogen activator Plasminogen activator inhibitor

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LUO Ju-hui
	XU-Zhong
	LONG Xin-cong
	LONG Yong-jian
	HU Hui-lian

Cite this article:

LUO Ju-hui,XU-Zhong,LONG Xin-cong, et al. Effect of Glutathione combined with Alprostadil treating acute kidney injury in sepsis[J]. 中国当代医药, 2020, 27(33): 43-46.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2020/V27/I33/43

[1]	于湘友，杜欣欣.脓毒症：争议中前行[J].中华危重病急救医学，2019，31（10）：1204-1207.
[2]	莫曼秋，潘玲，严官强，等.凝血指标与脓毒症相关急性肾损伤患者全因死亡的相关性分析[J].中华肾脏病杂志，2019，35（10）：758-764.
[3]	曾世永，林锦乐，张文武.脓毒症致急性肾损伤的研究进展[J].中华危重病急救医学，2018，30（7）：703-707.
[4]	亢宏山，白艳，刘淑红，等.严重脓毒症并发急性肾损伤的诊治进展[J].中国中西医结合急救杂志，2015，（4）：445-448.
[5]	Shankar-Hari M，Phillips GS，Levy ML，et al.Developing a New Definition and Assessing New Clinical Criteria for Septic Shock:For the Third International Consensus Definitions for Sepsis and Septic Shock （Sepsis-3）[J].JAMA，2016，315（8）：775-787.
[6]	Kidney Disease：Improving Global Outcomes （KDIGO)Acute Kidney Injury Work Group.KDIGO clinical practice guideline for acute kidney injury[J].Kidney Int Suppl，2012，2（1）：S1-S138.
[7]	钟南山，陆再英.内科学[M].8版.北京：人民卫生出版社，2008：149.
[8]	Sadaka F，Ethmaneabouelmaali C，Cytron MA，et al.Predicting mortality of patients with sepsis:a comparison of APACHE Ⅱand APACHE Ⅲscoring systems[J].J Clin Med Res，2017，9（11）：907-910.
[9]	杨乐天，赵宇亮，付平.脓毒症急性肾损伤的发病机制与诊治进展[J].中华肾脏病杂志，2019，35（9）：706-710.
[10]	张志雄，姜南，赵忠岩，等.脓毒症所致急性肾损伤的发病机制研究进展[J].中国实验诊断学，2019，23（10）：1853-1857.
[11]	艾庆娟，刘丽平，帅佃奎，等.前列地尔对脓毒性休克复苏达标患者急性肾损伤的影响[J].解放军医学杂志，2018，43（6）：499-503.
[12]	张林，白俐.还原型谷胱甘肽对脓毒症患者急性肾损伤的治疗作用[J].中国当代医药，2019，26（9）：54-56，60.
[13]	杜海勤，王国卿.前列地尔联合还原型谷胱甘肽治疗急性肾损伤30例疗效观察[J].陕西医学杂志，2015，44（9）：1175-1177.
[14]	朱恒梅，祝胜郎，陈结慧，等.miR-222 调控PARP-1 在高糖致人肾脏系膜细胞tPA/PAI-1 紊乱中的作用[J].新医学，2018，49（7）：502-506.
[15]	胡国鑫，彭锦，崔文娟，等.谷胱甘肽治疗脓毒症急性肾损伤患者血清tPA 和PAI-1 的影响[J].中华医院感染学杂志，2019，29（24）：3777-3780，3785.